NOTICE OF EXTRAORDINARY GENERAL MEETING IN MENDUS AB (PUBL)
Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13...
Stay updated with breaking news from Vitara Biomedical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13...
Anti-abortion advocates see promise in artificial womb technology, or AWT, for increasing the chances of survival outside of the womb for premature infants.
US regulators may approve human trials of a new device that offers hope to the parents of preterm babies.
A team of US researchers, who, in 2017, first carried out the ‘artificial womb’ experiment, are now seeking FDA approval for its tests on humans
Regulators are expected to consider clinical trials of the system which mimics the womb